BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2017.
World J Hepatol. Mar 18, 2017; 9(8): 427-435
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.427
Table 1 Patient characteristics directly before transplantation
Patients who survived (n = 68)Patients who died (n = 46)P-value (χ2 test)
Male39 (57%)31 (67%)NS
Age, yr (median, SD)16-65 (50.5, 13)17-69 (56.0, 12)0.009
BMI, range kg/m2 (median, SD)18-33 (23.1, 3)15-29 (25.9, 4)0.029
Pre-LTx creatinine, mg/dL (median, SD)0.4-3.5 (1.0, 0.5)0.3-2.9 (1.1, 0.6)NS
GFR, mL/min (median, SD)15.3-230.2 (73.3, 38.1)22.6- 240.4 (62.5, 48.0)NS
ALT, U/L (median, SD)4-2610 (35.5, 449.5)6-1566 (19.5, 339.0)NS
Gamma-GT, U/L (median, SD)7-374 (47.0, 8)13-184 (43.0, 45)NS
Bilirubin, mg/dL (median, SD)0.4-28.1 (2.4, 5.7)0.4-28.3 (2.4, 5.8)NS
Warm ischemia time, min (median, SD)25-100 (50.0, 18)22-75 (54.0, 15)NS
Cold ischemia time, min (median, SD)242-940 (542.5, 157)174-825 (521.0, 146)NS
Donor age, yr (median, SD)12-70 (36.5, 16)13-75 (41.0, 1)NS
Donor BMI, kg/m2 (median, SD)17-30 (23.5, 3)18-31 (24.2, 2)NS
Underlying diagnosis n (%)
HCC2 (3)3 (6)NS
Alcohol toxic liver cirrhosis12 (18)13 (27)NS
PSC4 (6)2 (4)NS
Autoimmune5 (8)2 (4)NS
HCV cirrhosis9 (14)6 (13)NS
HBV infection16 (24)5 (10)0.049
Other18 (27)17 (35)NS


Write to the Help Desk